Samsara BioCapital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 86
  • Portfolio
  • 46
  • Exits
  • 25
Exits

Samsara BioCapital General Information

Description

Founded in 2016, Samsara BioCapital is a venture capital firm based in Palo Alto, California. The firm seeks to invest in the life sciences, oncology and digital healthcare sectors.

Contact Information

Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 628 Middlefield Road
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Samsara BioCapital Investments (86)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Abata Therapeutics 23-Jun-2021 Early Stage VC 0000 Biotechnology Startup
0000000000 10-Jun-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials 00000000 00000000 00.0
00000000 08-Jun-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials
000000 00000000000 26-May-2021 00000 00000 00000 Drug Discovery Clinical Trials - General
000000 000 00 18-May-2021 00000 00000 0000 Therapeutic Devices Generating Revenue 000 000000
0000000 00 07-May-2021 0000 00000 Enterprise Systems (Healthcare) Generating Revenue
00000 000000000000 20-Apr-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1
00000 00000000 20-Apr-2021 00000 00000 00000 Biotechnology Generating Revenue
Tango Therapeutics 14-Apr-2021 PIPE 00000 Drug Discovery Pre-Clinical Trials
Arcellx 09-Apr-2021 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 1 0000000 00000 00.0
You’re viewing 10 of 86 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Samsara BioCapital Exits (25)

Company Name Exit Date Exit Type Exit Size
Elevation Oncology 25-Jun-2021 IPO 00000
00000000 000 25-Jun-2021 000 00000
00000 000000000000 11-Jun-2021 000 00000
00000000 000000000 28-May-2021 000 00000
0000 000000000000 23-Apr-2021 000 00000
000000000 16-Apr-2021 000 00000
0000000 24-Feb-2021 0000000 000000
0000000 0000000000 12-Feb-2021 000 00000
Bolt Biotherapeutics 05-Feb-2021 IPO 00000
Terns Pharmaceuticals 05-Feb-2021 IPO 00000
You’re viewing 10 of 25 exits. Get the full list »

Samsara BioCapital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Samsara BioCapital Team (12)

Name Title Deals Funds Boards Office
Richard Van Doren Jr. Chief Financial Officer Palo Alto, CA
Srinivas Akkaraju Ph.D Founder & Managing General Partner 00 0 00 Palo Alto, CA
Stephen Shuttleworth Ph.D Venture Partner Palo Alto, CA
Michael Dybbs Ph.D Partner 00 0 0 Palo Alto, CA
Cory Freedland Ph.D Principal 0 0 0 Palo Alto, CA
You’re viewing 5 of 12 team members. Get the full list »

Samsara BioCapital Co-Investors (237)

Name With Exits Lead Partner Series Industry
Cormorant Asset Management 12 0 0 Series chart Industry bar
Janus Henderson Investors 00 0 0 Series chart Industry bar
Casdin Capital 00 0 Series chart Industry bar
EcoR1 Capital 00 0 0 Series chart Industry bar
Citadel (Hedge Fund) 0 0 0 Series chart Industry bar
You’re viewing 5 of 237 co-investors. Get the full list »